O	O	0	8	Impaired	Impaired	B-NP	JJ	O	4	NMOD	O
O	O	9	14	fetal	fetal	I-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	15	24	thymocyte	thymocyte	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	25	36	development	development	I-NP	NN	O	0	ROOT	O
O	O	37	42	after	after	B-PP	IN	O	4	NMOD	O
O	O	43	52	efficient	efficient	B-NP	JJ	O	7	NMOD	O
O	O	53	63	adenovirus	adenovirus	I-NP	NN	O	5	PMOD	O
O	O	63	64	-	-	B-VP	HYPH	O	7	NMOD	O
O	O	64	72	mediated	mediate	B-NP	VBN	O	10	NMOD	O
O	O	73	83	inhibition	inhibition	I-NP	NN	O	8	OBJ	O
O	O	84	86	of	of	B-PP	IN	O	10	NMOD	O
T7	B-Entity	87	89	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T7	I-Entity	89	90	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T7	I-Entity	90	95	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T7	I-Entity	96	97	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	98	108	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	108	109	.	.	O	.	O	4	P	O

O	O	111	113	We	We	B-NP	PRP	O	2	SUB	O
O	O	114	123	introduce	introduce	B-VP	VBP	O	0	ROOT	O
O	O	124	125	a	a	B-NP	DT	O	6	NMOD	O
O	O	126	129	new	new	I-NP	JJ	O	6	NMOD	O
O	O	130	142	experimental	experimental	I-NP	JJ	O	6	NMOD	O
O	O	143	149	system	system	I-NP	NN	O	2	OBJ	O
O	O	150	159	combining	combine	B-VP	VBG	O	6	NMOD	O
O	O	160	170	adenovirus	adenovirus	B-NP	NN	O	17	NMOD	O
O	O	170	171	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	171	179	mediated	mediate	I-NP	VBN	O	17	NMOD	O
O	O	180	184	gene	gene	I-NP	NN	O	12	NMOD	O
O	O	185	193	transfer	transfer	I-NP	NN	O	17	NMOD	O
O	O	194	197	and	and	O	CC	O	17	NMOD	O
O	O	198	203	fetal	fetal	B-NP	JJ	O	17	NMOD	O
O	O	204	210	thymic	thymic	I-NP	JJ	O	17	NMOD	O
O	O	211	216	organ	organ	I-NP	NN	O	17	NMOD	O
O	O	217	224	culture	culture	I-NP	NN	O	7	OBJ	O
O	O	225	226	(	(	O	(	O	20	DEP	O
O	O	226	230	FTOC	FTOC	B-NP	NN	B-cell_line	20	DEP	B-cell_line
O	O	230	231	)	)	O	)	O	17	NMOD	O
O	O	231	232	.	.	O	.	O	2	P	O

O	O	233	237	This	This	B-NP	DT	O	2	NMOD	O
O	O	238	244	system	system	I-NP	NN	O	3	SUB	O
O	O	245	252	allowed	allow	B-VP	VBD	O	0	ROOT	O
O	O	253	255	us	us	B-NP	PRP	O	7	SUB	O
O	O	256	258	to	to	B-VP	TO	O	7	VMOD	O
O	O	259	270	efficiently	efficiently	I-VP	RB	O	7	VMOD	O
O	O	271	278	express	express	I-VP	VB	O	3	VMOD	O
O	O	279	281	in	in	B-PP	IN	O	7	VMOD	O
O	O	282	292	developing	develop	B-VP	VBG	O	10	NMOD	O
O	O	293	303	thymocytes	thymocyte	B-NP	NNS	B-cell_type	8	PMOD	B-cell_type
O	O	304	305	a	a	B-NP	DT	O	13	NMOD	O
O	O	306	312	mutant	mutant	I-NP	JJ	O	13	NMOD	O
O	O	313	317	form	form	I-NP	NN	O	7	OBJ	O
O	O	318	320	of	of	B-PP	IN	O	13	NMOD	O
O	O	321	324	the	the	B-NP	DT	O	24	NMOD	O
T8	B-Entity	325	327	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T8	I-Entity	327	328	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T8	I-Entity	328	333	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T8	I-Entity	334	335	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	336	345	inhibitor	inhibitor	I-NP	NN	O	24	NMOD	O
T1	B-Protein	346	347	I	I	I-NP	NN	B-protein	24	NMOD	B-protein
T1	I-Protein	348	353	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T1	I-Protein	354	355	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T1	I-Protein	356	361	alpha	alpha	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	362	363	(	(	O	(	O	31	DEP	O
T2	B-Protein	363	366	mut	mut	B-NP	NN	O	30	NMOD	O
T2	I-Protein	366	367	-	-	B-NP	HYPH	O	30	P	O
T2	I-Protein	367	368	I	I	I-NP	NN	B-protein	30	NMOD	B-protein
T2	I-Protein	369	374	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T2	I-Protein	375	376	B	B	I-NP	NN	I-protein	31	DEP	I-protein
O	O	376	377	)	)	O	)	O	24	NMOD	O
O	O	378	381	and	and	O	CC	O	7	VMOD	O
O	O	382	384	to	to	B-VP	TO	O	34	VMOD	O
O	O	385	390	study	study	I-VP	VB	O	7	VMOD	O
O	O	391	394	the	the	B-NP	DT	O	37	NMOD	O
O	O	395	405	maturation	maturation	I-NP	NN	O	37	NMOD	O
O	O	406	413	defects	defect	I-NP	NNS	O	34	OBJ	O
O	O	414	423	occurring	occur	B-VP	VBG	O	37	NMOD	O
O	O	424	428	when	when	B-ADVP	WRB	O	38	VMOD	O
T9	B-Entity	429	431	NF	NF	B-NP	NN	B-protein	44	NMOD	B-protein
T9	I-Entity	431	432	-	-	B-NP	HYPH	I-protein	44	NMOD	I-protein
T9	I-Entity	432	437	kappa	kappa	I-NP	NN	I-protein	44	NMOD	I-protein
T9	I-Entity	438	439	B	B	I-NP	NN	I-protein	44	NMOD	I-protein
O	O	440	450	activation	activation	I-NP	NN	O	45	SUB	O
O	O	451	453	is	be	B-VP	VBZ	O	39	SBAR	O
O	O	454	463	inhibited	inhibit	I-VP	VBN	O	45	VC	O
O	O	464	470	during	during	B-PP	IN	O	46	VMOD	O
O	O	471	476	fetal	fetal	B-NP	JJ	O	49	NMOD	O
O	O	477	488	development	development	I-NP	NN	O	47	PMOD	O
O	O	488	489	.	.	O	.	O	3	P	O

O	O	490	495	Fetal	Fetal	B-NP	JJ	B-cell_type	2	NMOD	B-cell_type
O	O	496	506	thymocytes	thymocyte	I-NP	NNS	I-cell_type	12	SUB	I-cell_type
O	O	507	515	infected	infect	B-VP	VBN	O	2	NMOD	O
O	O	516	520	with	with	B-PP	IN	O	3	VMOD	O
O	O	521	531	adenovirus	adenovirus	B-NP	NN	O	4	PMOD	O
O	O	532	542	containing	contain	B-VP	VBG	O	5	NMOD	O
O	O	543	546	mut	mut	B-NP	NN	O	11	NMOD	O
O	O	546	547	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	547	548	I	I	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	549	554	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	555	556	B	B	I-NP	NN	I-protein	6	OBJ	I-protein
O	O	557	561	were	be	B-VP	VBD	O	0	ROOT	O
O	O	562	567	found	find	I-VP	VBN	O	12	VC	O
O	O	568	570	to	to	I-VP	TO	O	15	VMOD	O
O	O	571	578	develop	develop	I-VP	VB	O	13	VMOD	O
O	O	579	587	normally	normally	B-ADVP	RB	O	15	VMOD	O
O	O	588	593	until	until	B-SBAR	IN	O	15	VMOD	O
O	O	594	597	the	the	B-NP	DT	O	26	NMOD	O
T3	B-Protein	598	602	CD44	CD44	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	602	603	-	-	B-NP	HYPH	O	22	P	O
T4	B-Protein	603	607	CD25	CD25	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	607	608	+	+	B-NP	SYM	O	26	NMOD	O
O	O	608	609	,	,	O	,	O	26	P	O
T5	B-Protein	610	613	CD4	CD4	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	613	614	-	-	B-NP	HYPH	O	26	P	O
T10	B-Entity	614	617	CD8	CD8	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	617	618	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	619	625	double	double	I-NP	JJ	O	31	NMOD	O
O	O	625	626	-	-	I-NP	HYPH	O	31	NMOD	O
O	O	626	634	negative	negative	I-NP	JJ	O	31	NMOD	O
O	O	635	640	stage	stage	I-NP	NN	O	46	SUB	O
O	O	640	641	,	,	O	,	O	31	P	O
O	O	642	647	while	while	B-SBAR	IN	O	31	NMOD	O
O	O	648	658	production	production	B-NP	NN	O	33	PMOD	O
O	O	659	661	of	of	B-PP	IN	O	34	NMOD	O
O	O	662	666	more	more	B-NP	RBR	O	37	AMOD	O
O	O	667	673	mature	mature	I-NP	JJ	O	45	NMOD	O
O	O	674	680	double	double	I-NP	JJ	O	45	NMOD	O
O	O	680	681	-	-	I-NP	HYPH	O	45	NMOD	O
O	O	681	689	positive	positive	I-NP	JJ	O	45	NMOD	O
O	O	690	693	and	and	I-NP	CC	O	45	NMOD	O
O	O	694	700	single	single	I-NP	JJ	O	45	NMOD	O
O	O	700	701	-	-	I-NP	HYPH	O	45	NMOD	O
O	O	701	709	positive	positive	I-NP	JJ	B-cell_type	45	NMOD	B-cell_type
O	O	710	721	populations	population	I-NP	NNS	I-cell_type	35	PMOD	I-cell_type
O	O	722	725	was	be	B-VP	VBD	O	17	SBAR	O
O	O	726	734	strongly	strongly	I-VP	RB	O	46	VMOD	O
O	O	735	744	decreased	decrease	I-VP	VBN	O	46	VC	O
O	O	744	745	.	.	O	.	O	12	P	O

O	O	746	759	Proliferation	Proliferation	B-NP	NN	O	12	SUB	O
O	O	759	760	,	,	O	,	O	1	P	O
O	O	761	763	as	as	B-SBAR	IN	O	1	NMOD	O
O	O	764	772	measured	measure	B-VP	VBN	O	3	SBAR	O
O	O	773	775	by	by	B-PP	IN	O	4	VMOD	O
O	O	776	779	the	the	B-NP	DT	O	7	NMOD	O
O	O	780	790	percentage	percentage	I-NP	NN	O	5	PMOD	O
O	O	791	793	of	of	B-PP	IN	O	7	NMOD	O
O	O	794	799	cells	cell	B-NP	NNS	O	8	PMOD	O
O	O	800	802	in	in	B-PP	IN	O	9	NMOD	O
O	O	803	808	cycle	cycle	B-NP	NN	O	10	PMOD	O
O	O	809	817	appeared	appear	B-VP	VBD	O	0	ROOT	O
O	O	818	824	normal	normal	B-ADJP	JJ	O	12	PRD	O
O	O	824	825	,	,	O	,	O	12	P	O
O	O	826	828	as	as	B-SBAR	IN	O	12	VMOD	O
O	O	829	832	did	do	O	VBD	O	15	DEP	O
O	O	833	846	rearrangement	rearrangement	B-NP	NN	O	19	NMOD	O
O	O	847	850	and	and	O	CC	O	19	NMOD	O
O	O	851	861	expression	expression	B-NP	NN	O	16	SUB	O
O	O	862	864	of	of	B-PP	IN	O	19	NMOD	O
O	O	865	868	the	the	B-NP	DT	O	25	NMOD	O
T6	B-Protein	869	872	TCR	TCR	I-NP	NN	B-protein	25	NMOD	B-protein
T6	I-Protein	873	877	beta	beta	B-VP	SYM	I-protein	25	NMOD	I-protein
T6	I-Protein	877	878	-	-	O	HYPH	I-protein	25	NMOD	I-protein
T6	I-Protein	878	883	chain	chain	B-NP	NN	I-protein	20	PMOD	I-protein
O	O	883	884	.	.	O	.	O	12	P	O

O	O	885	892	However	However	B-ADVP	RB	O	4	VMOD	O
O	O	892	893	,	,	O	,	O	4	P	O
O	O	894	903	apoptosis	apoptosis	B-NP	NN	O	4	SUB	O
O	O	904	907	was	be	B-VP	VBD	O	0	ROOT	O
O	O	908	912	much	much	B-ADJP	RB	O	6	AMOD	O
O	O	913	919	higher	high	I-ADJP	JJR	O	4	PRD	O
O	O	920	922	in	in	B-PP	IN	O	4	VMOD	O
O	O	923	927	FTOC	FTOC	B-NP	NN	O	7	PMOD	O
O	O	928	936	infected	infect	B-VP	VBN	O	8	NMOD	O
O	O	937	941	with	with	B-PP	IN	O	9	VMOD	O
O	O	942	952	adenovirus	adenovirus	B-NP	NN	O	10	PMOD	O
O	O	953	963	containing	contain	B-VP	VBG	O	11	NMOD	O
O	O	964	967	mut	mut	B-NP	NN	O	17	NMOD	O
O	O	967	968	-	-	I-NP	HYPH	O	17	P	O
O	O	968	969	I	I	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	970	975	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	976	977	B	B	I-NP	NN	I-protein	12	OBJ	I-protein
O	O	978	982	than	than	B-PP	IN	O	4	VMOD	O
O	O	983	985	in	in	B-PP	IN	O	18	PMOD	O
O	O	986	990	FTOC	FTOC	B-NP	NN	O	19	PMOD	O
O	O	991	999	infected	infect	B-VP	VBN	O	20	NMOD	O
O	O	1000	1004	with	with	B-PP	IN	O	21	VMOD	O
O	O	1005	1006	a	a	B-NP	DT	O	25	NMOD	O
O	O	1007	1014	control	control	I-NP	NN	O	25	NMOD	O
O	O	1015	1020	virus	virus	I-NP	NN	O	22	PMOD	O
O	O	1020	1021	.	.	O	.	O	4	P	O

O	O	1022	1027	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	1028	1036	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	1036	1037	,	,	O	,	O	6	P	O
O	O	1038	1043	these	these	B-NP	DT	O	5	NMOD	O
O	O	1044	1051	results	result	I-NP	NNS	O	6	SUB	O
O	O	1052	1059	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1060	1064	that	that	B-SBAR	IN	O	6	VMOD	O
T11	B-Entity	1065	1067	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T11	I-Entity	1067	1068	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T11	I-Entity	1068	1073	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T11	I-Entity	1074	1075	B	B	I-NP	NN	I-protein	12	SUB	I-protein
O	O	1076	1081	plays	play	B-VP	VBZ	O	7	SBAR	O
O	O	1082	1083	a	a	B-NP	DT	O	15	NMOD	O
O	O	1084	1091	crucial	crucial	I-NP	JJ	O	15	NMOD	O
O	O	1092	1096	role	role	I-NP	NN	O	12	OBJ	O
O	O	1097	1099	in	in	B-PP	IN	O	12	VMOD	O
O	O	1100	1108	ensuring	ensure	B-VP	VBG	O	16	PMOD	O
O	O	1109	1112	the	the	B-NP	DT	O	21	NMOD	O
O	O	1113	1128	differentiation	differentiation	I-NP	NN	O	21	NMOD	O
O	O	1129	1132	and	and	I-NP	CC	O	21	NMOD	O
O	O	1133	1141	survival	survival	I-NP	NN	O	17	OBJ	O
O	O	1142	1144	of	of	B-PP	IN	O	21	NMOD	O
O	O	1145	1155	thymocytes	thymocyte	B-NP	NNS	B-cell_type	22	PMOD	B-cell_type
O	O	1156	1158	in	in	B-PP	IN	O	21	NMOD	O
O	O	1159	1162	the	the	B-NP	DT	O	27	NMOD	O
O	O	1163	1168	early	early	I-NP	JJ	O	27	NMOD	O
O	O	1169	1175	stages	stage	I-NP	NNS	O	24	PMOD	O
O	O	1176	1178	of	of	B-PP	IN	O	27	NMOD	O
O	O	1179	1184	their	their	B-NP	PRP$	O	30	NMOD	O
O	O	1185	1196	development	development	I-NP	NN	O	28	PMOD	O
O	O	1196	1197	.	.	O	.	O	6	P	O
